Select Medical Holdings SEM Cash and cash equivalents, end of period

Cash and cash equivalents, end of period at other companies

Phillips 66PSX

$5.15B+246%

Arthur J. GallagherAJG

$8.48B-61.9%

3MMMM

$3.73B-41.1%

eBayEBAY

$4.23B+1.9%

American Financial GroupAFG

$1.35B+6.0%

Erie Indemnity CompanyERIE

$268.62M+3.2%

Other financials

Income statement

See full

Revenue$1.4B+5.0%

Gross profit$175.5M-2.8%

Operating income$98.4M-12.7%

Net income$44.0M-22.4%

EPS (diluted)$0.35-20.5%

Balance sheet

See full

Cash & equivalents$25.7M-51.7%

Total debt$3.0B+7.5%

Total equity$1.8B+2.1%

Total assets$6.0B+6.1%

Cash flow

See full

Operating cash flow$37.9M+1,195%

CapEx$58.9M+12.5%

Free cash flow-$21.0M+62.3%

Valuation

See full

Market cap$2.05B-6.2%

Profitability

See full

Gross margin11.3%-0.5pp

Operating margin5.8%+0.8pp

Net margin2.4%-0.9pp

FCF margin2.8%-4.1pp

Returns & leverage

See full

Return on equity7.7%-3.6pp

Debt / equity1.7×+0.1×

Current ratio1.1×0.0×

Where this comes from

Reported directly by Select Medical Holdings in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Select Medical Holdings’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Select Medical Holdings's cash and cash equivalents, end of period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Select Medical Holdings's cash and cash equivalents, end of period?: Select Medical Holdings (SEM) reported cash and cash equivalents, end of period of $25.68M in Q1 2026.